Key result
Acenocoumarol is an effective oral vitamin K antagonist with a rapid onset and offset of action that is widely used for the prophylaxis and management of thromboembolic disorders.
Why the study?
Does acenocoumarol improve INR stability and efficacy compared to warfarin in patients with thromboembolic disorders?
Does acenocoumarol improve INR stability and efficacy compared to warfarin in patients with thromboembolic disorders?
Acenocoumarol remains a widely used and effective oral anticoagulant with rapid onset and offset of action, potentially offering better INR stability than warfarin.
No takes yet. Share an insight, caveat, or question.
Acenocoumarol remains a viable VKA option; leaves open whether it improves INR stability versus warfarin.
Abhijit Trailokya (2015) conducted a review in Thromboembolic disorders. Acenocoumarol vs. Warfarin was evaluated. Acenocoumarol is an effective oral vitamin K antagonist with a rapid onset and offset of action that is widely used for the prophylaxis and management of thromboembolic disorders.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: